Instigo-L Tablet SR
Manufacturer
Mebio Labs Pvt Ltd
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Key Information
Short Description
Instigo-L Tablet SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Dosage Form
Tablet SR
Introduction
Instigo-L Tablet SR is a combination of two medicines: Levosulpiride and Rabeprazole. It reduces excess acid production in the stomach and prevents the reflux of stomach acid into the food pipe. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect or be affected by this medicine.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Instigo-L Tablet SR is to be taken empty stomach.
Safety Information
Side Effects
The most common side effects are nausea, stomach pain, diarrhea, flatulence, constipation, headache, weakness, and flu-like symptoms.
Alcohol Warning
It is unsafe to consume alcohol with Instigo-L Tablet SR.
Breastfeeding Warning
Information regarding the use of Instigo-L Tablet SR during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Instigo-L Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Instigo-L Tablet SR is a combination of two medicines: Levosulpiride and Rabeprazole.
Quick Tips
Do not consume alcohol while taking Instigo-L Tablet SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Instigo-L Tablet SR for longer than prescribed.
Related Medicines
Cyra-LS Tablet
Rabekind-Plus Tablet
Rekool-L Tablet
Zomart LS 75mg/20mg Tablet SR
Rabeto LS 75mg/20mg Tablet SR
Rabejan L 75mg/20mg Tablet SR
Tomrab L 75mg/20mg Tablet SR
Mirale LSR Tablet
Epsirab-L sr 75mg/20mg Tablet
Jetrab LS 75mg/20mg Tablet SR
Frequently asked questions
What is the recommended timing for Instigo-L Tablet SR administration?
Take Instigo-L Tablet SR exactly as prescribed by your doctor. It is best to take one capsule daily on an empty stomach.
Are there any contraindications associated with using Instigo-L Tablet SR?
Do not use Instigo-L Tablet SR in patients who have a known allergy to any of its components or excipients. If you have an allergic reaction, seek immediate medical attention.
Can dizziness occur while taking Instigo-L Tablet SR?
Yes, some patients may experience dizziness (feeling faint, weak, unsteady, or lightheaded) after taking Instigo-L Tablet SR. If you feel dizzy or lightheaded, rest in a safe environment until symptoms subside.
Does Instigo-L Tablet SR increase the risk of fractures?
Some studies suggest that long-term use of Instigo-L Tablet SR may increase the risk of osteoporosis-related fractures in the hip, wrist, or spine. The risk is higher with high doses (multiple daily doses and prolonged treatment exceeding a year). Consult your doctor for further information.
Is it safe to drive while taking Instigo-L Tablet SR?
Instigo-L Tablet SR can cause drowsiness, dizziness, or blurred vision. Therefore, do not operate heavy machinery or drive until you understand how the medication affects you.
How should I store and dispose of Instigo-L Tablet SR?
Store this medicine in its original packet or container, tightly sealed. Store it according to the instructions provided on the label or packaging. Dispose of unused medication properly by following local regulations. Keep it out of reach of children, pets, and other unauthorized individuals.
